Skip navigation
DSpace logo
BelSU DSpace logo

  1. Welcome to the Open access repository!

Browsing by Subject endothelial dysfunction

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я
or enter first few letters:  
Showing results 1 to 20 of 56  next >
Issue DateTitleAuthor(s)
2011Arginase inhibitor in the pharmacological correction of endothelial dysfunctionPokrovskiy, M. V.; Korokin, M. V.; Tsepeleva, S. A.; Pokrovskaya, T. G.; Kochkarov, V. I.
2019Betahistine: targeting on vascular wall agingSolgalova, A. S.; Soldatov, V. O.; Pokrovskaya, T. G.; Puchenkova, O. A.; Zapesotskaya, S. Ya.; Feitelson, A. V.; Sernov, L. N.; Provotorov, V. Ya.; Pahlevanyan, V. G.
2016Cardiovascular effects of an arginase II selective inhibitorYakushev, V. I.; Pokrovskii, M. V.
2019Combination of captopril and darbepoetin alfa attenuate radiation-induced-endothelial dysfunctionSaroyan, K. V.; Sytnik, M. V.; Miller, E. S.; Puchenkova, O. A.; Soldatov, V. O.; Gashevskaya, A. S.; Artyushkova, E. B.; Gudyrev, O. S.
2020Comparative study of the pharmacological effects of Venarus Plus, Venarus, and Detralex on L-NAME-induced endothelial dysfunction, venous tone and platelet aggregationLukyanova, Y. S.; Gureev, V. V.; Kolesnichenko, P. D.; Danilenko, L. M.; Gudyrev, O. S.; Pokrovskaya, T. G.
2015Concomitant use of statins and s-(2-boron-ethyl)-l-cysteine arginase inhibitor to correct endotoxin-induced endothelial dysfunctionDenisiuk, T. A.; Demchenko, S. A.; Saroyan, K. V.
2015Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010Gureev, V. V.; Martynova, O. V.; Anciferova, O. E.; Martynov, M. A.; Pokrovskaia, T. G.
2019Correction of asymmetric dimethylarginine-like pre-eclampsia in rats by micronized purified flavonoids fractionAntsiferova, O. E.; Yurakova, A. V.; Lukyanova, Y. S.; Gureev, V. V.; Korokin, M. V.
2020Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsiaLokteva, T. I.; Rozhkov, I. S.; Gureev, V. V.; Gureeva, A. V.; Zatolokina, M. A.
2018Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experimentElagin, V. V.; Bratchikov, O. I.; Zatolokina, M. A.
2008Development of endothelial dysfunction in system Mother-Placenta-Fetus at hypertensive disease in gravidaePavlova, T. V.; Selivanova, A. V.
2023Dynamics of endothelial function indexes in patients with post-Covid syndrome using a combination drug of ethylmethylhydroxyperidine succinate/vitamin B6Mikhailova, L. V.; Belousova, Ya. D.; Moiseeva, E. M.; Tsapkova, A. A.; Gazatova, N. D.
2018Endothelial dysfunction: comparative evaluation of ultrasound dopplerography, laser dopplerflowmetry and direct monitoring of arterial pressure for conducting pharmacological tests in ratsSoldatov, V. O.; Malorodova, T. N.; Balamutova, T. I.; Ksenofontov, A. O.; Dovgan, A. P.
2022Endothelial dysfunction: developmental mechanisms and therapeutic strategiesShcheblykin, D. V.; Bolgov, A. A.; Pokrovskii, M. V.; Stepenko, Yu. V.; Tsuverkalova, Y. M.; Shcheblykina, O. V.; Korokina, L. V.
2020Endothelial protective properties of short-chain peptides that mimic α-helix B of erythropoietin in experimental preeclampsiaGolubev, I. V.; Gureev, V. V.; Korokin, M. V.; Gureeva, A. V.; Polyanskaya, A. V.; Pokrovskii, M. V.; Lazareva, G. A.; Bystrova, N. A.
2016Endothelio- and cardioprotective effects of vitamin B₆ and folic acid in modelling methionine-induced hyperhomocysteinemiaProvotorov, V. Y.; Korokin, M. V.; Pokrovskii, M. V.; Povetkin, S. V.; Lazareva, G. A.
2016Endothelioprotective property of the combination of the thioctic acid and rosuvastatin shown in the endothelial dysfunction modelsMolchanova, O. V.; Pokrovskaya, T. G.; Povetkin, S. V.; Reznikov, K. M.
2016Endothelium and cardioprotective effects of hmg-co-a-reductase in combination with l-arginine In endothelial dysfunction modelingDenisyuk, T. A.; Lazareva, G. A.; Provotorov, V. Y.; Shaposhnikov, A. A.
2018Endothelotropic activity of 4-hydroxy-3,5-di-tret-butylcinnamic acid in the conditions of experimental cerebral ischemiaVoronkov, A. V.; Pozdnyakov, D. I.
2020Erythropoietin mimetic peptide (pHBSP) corrects endothelial dysfunction in a rat model of preeclampsiaKorokin, M.; Gureev, V.; Gudyrev, O.; Golubev, I.; Korokina, L.; Peresypkina, A.; Pokrovskaia, T.
Showing results 1 to 20 of 56  next >